Results

Total Results: 27 records

Showing results for "kidney disease".

1. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/18/2023_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
   January 01, 2023 - ESRD, ESRD encounter, dialysis procedure, and dependence on dialysis as exclusions: Chronic kidney disease … The ACC states, “People with chronic kidney disease are at higher risk of side effects from lipid medications … Kidney Disease: Improving Global Outcomes (KDIGO) organization (a group of nephrologists, lipid specialists … The ACC further states, “People with chronic kidney disease are at higher risk of side effects from … Lipid Management Guidelines for Adults with Chronic Kidney Disease.

2. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
   January 01, 2024 - ESRD, ESRD encounter, dialysis procedure, and dependence on dialysis as exclusions: Chronic kidney disease … Kidney Disease: Improving Global Outcomes (KDIGO) organization (a group of nephrologists, lipid specialists … states, “People with chronic kidney disease are at higher risk of side effects from lipid medications … Lipid Management Guidelines for Adults with Chronic Kidney Disease. … AMIA Annu Symp Proc. 2016;2016:1189- 1198. 26 Kidney Disease: Improving Global Outcomes (KDIGO) Lipid

3. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation_Guide_CDS_Connect_Statin_CVD_Clinician_Facing_0.pdf
   September 01, 2022 - ESRD, ESRD encounter, dialysis procedure, and dependence on dialysis as exclusions: Chronic kidney disease … Kidney Disease: Improving Global Outcomes (KDIGO) organization (a group of nephrologists, lipid specialists … states “People with chronic kidney disease are at higher risk of side effects from lipid medications … Lipid Management Guidelines for Adults with Chronic Kidney Disease. … Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group.

4. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
   January 01, 2024 - Chronic kidney disease has been associated with an increased risk of CVD.14 However, multiple studies … states “People with chronic kidney disease are at higher risk of side effects from lipid medications … Lipid Management Guidelines for Adults with Chronic Kidney Disease. … AMIA Annu Symp Proc. 2016;2016:1189- 1198. 29 Kidney Disease: Improving Global Outcomes (KDIGO) Lipid … KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease.

5. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
   January 01, 2023 - Chronic kidney disease has been associated with an increased risk of CVD.13 However, multiple studies … states “People with chronic kidney disease are at higher risk of side effects from lipid medications … Lipid Management Guidelines for Adults with Chronic Kidney Disease. … AMIA Annu Symp Proc. 2016;2016:1189- 1198. 30 Kidney Disease: Improving Global Outcomes (KDIGO) Lipid … KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease.

6. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1056/508_2022_CDS_Connect_IG_Statin_CVD_Patient_Facing_final.pdf
   January 01, 2022 - Chronic kidney disease has been associated with an increased risk of CVD. … The ACC further 30 states “People with chronic kidney disease are at higher risk of side effects from … Lipid Management Guidelines for Adults with Chronic Kidney Disease. … Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group. … KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease.

7. Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention.pdf
   January 01, 2020 - Kidney Disease: Improving Global Outcomes (KDIGO) organization (a group of nephrologists, lipid specialists … states, “People with chronic kidney disease are at higher risk of side effects from lipid medications … Lipid Management Guidelines for Adults with Chronic Kidney Disease - American College of Cardiology. … Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group. … KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease.

8. Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1056/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Patient%20Facing%20CDS%20Intervention_Final.pdf
   September 01, 2019 - Kidney Disease: Improving Global Outcomes (KDIGO) organization (a group of nephrologists, lipid specialists … states, “People with chronic kidney disease are at higher risk of side effects from lipid medications … Lipid Management Guidelines for Adults with Chronic Kidney Disease - American College of Cardiology. … Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group. … KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease.

9. Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (April 2021) (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention_2.pdf
   April 01, 2021 - Kidney Disease: Improving Global Outcomes (KDIGO) organization (a group of nephrologists, lipid specialists … states, “People with chronic kidney disease are at higher risk of side effects from lipid medications … Lipid Management Guidelines for Adults with Chronic Kidney Disease - American College of Cardiology. … Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group. … KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease.

10. Statin Use for the Primary Prevention of CVD in Adults: Patient-facing CDS Intervention (April 2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Patient%20Facing%20CDS%20Intervention_Final_1.pdf
    April 01, 2021 - Chronic kidney disease has been associated with an increased risk of CVD. … states, “People with chronic kidney disease are at higher risk of side effects from lipid medications … Lipid Management Guidelines for Adults with Chronic Kidney Disease - American College of Cardiology. … Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group. … KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease.

11. Pain Management Summary Clincial Decision Support Toolkit For Repository (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository.xlsx
    January 01, 2003 - disease, stage 1 313792 Aluminum Hydroxide 45 MG/ML / Magnesium Hydroxide 40 MG/ML Oral Suspension … N18.2 Chronic kidney disease, stage 2 (mild) 313863 Bisacodyl 5 MG Rectal Suppository … N18.3 Chronic kidney disease, stage 3 (moderate) 314087 Magnesium Hydroxide 240 MG/ML Oral Suspension … N18.4 Chronic kidney disease, stage 4 (severe) 314113 Magnesium Oxide 200 MG Oral Tablet … N18.5 Chronic kidney disease, stage 5 317055 Aluminum Hydroxide 200 MG / Magnesium Hydroxide 200 MG

12. Pain Management Summary Clincial Decision Support Toolkit For Repository 0 (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
    January 01, 2003 - disease, stage 1 313792 Aluminum Hydroxide 45 MG/ML / Magnesium Hydroxide 40 MG/ML Oral Suspension … N18.2 Chronic kidney disease, stage 2 (mild) 313863 Bisacodyl 5 MG Rectal Suppository … N18.3 Chronic kidney disease, stage 3 (moderate) 314087 Magnesium Hydroxide 240 MG/ML Oral Suspension … N18.4 Chronic kidney disease, stage 4 (severe) 314113 Magnesium Oxide 200 MG Oral Tablet … N18.5 Chronic kidney disease, stage 5 317055 Aluminum Hydroxide 200 MG / Magnesium Hydroxide 200 MG

13. 2022 Intervention Content T2Dm Counseling (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1066/2022_Intervention_Content_T2DM_Counseling.xlsx
    January 01, 2022 - : This web-based resource goes to an NIH site, the National Institute of Diabetes and Digestive and Kidney … Diseases.

14. 2023 Intervention Content T2Dm Part Two Counseling (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1066/2023_Intervention_Content_T2DM_Part_Two_Counseling.xlsx
    January 01, 2023 - : This web-based resource goes to an NIH site, the National Institute of Diabetes and Digestive and Kidney … Diseases.

15. Healthy Diet And Physical Activity Intervention Content 1 (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1071/Healthy%20Diet%20and%20Physical%20Activity_Intervention%20Content_1.xlsx
    January 01, 2012 - : This web-based resource goes to an NIH site, the National Institute of Diabetes and Digestive and Kidney … Diseases.

16. 2024 Intervention Content Prediabetes And Type 2 Diabetes Part One Screening (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_Intervention_Content_Prediabetes_and_Type_2_Diabetes_Part_one_Screening.xlsx
    January 01, 2024 - Example Intervention Text Example Patient-Facing Intervention Text: Prediabetes and Type 2 Diabetes: Part 1, Screening General Information The example intervention text shown below is embedded in the Clinical Quality Language (CQL) files for the Prediabetes and Type 2 Diabetes Part One: Screening artifact. Imple…

17. 2023 Intervention Content Diet Activity (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1071/2023_Intervention_Content_Diet_Activity.xlsx
    January 01, 2023 - : This web-based resource goes to an NIH site, the National Institute of Diabetes and Digestive and Kidney … Diseases.

18. 2022 Intervention Content Prediabetes And Type 2 Diabetes Part One Screening (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/2022_Intervention_Content_Prediabetes_and_Type_2_Diabetes_Part_one_Screening.xlsx
    January 01, 2022 - Example Intervention Text Example Patient-Facing Intervention Text: Prediabetes and Type 2 Diabetes: Part 1, Screening General Information The example intervention text shown below is embedded in the Clinical Quality Language (CQL) files for the Prediabetes and Type 2 Diabetes Part One: Screening artifact. Imple…

19. 2023 Intervention Content Prediabetes And Type 2 Diabetes Part One Screening (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/2023_Intervention_Content_Prediabetes_and_Type_2_Diabetes_Part_one_Screening.xlsx
    January 01, 2023 - Example Intervention Text Example Patient-Facing Intervention Text: Prediabetes and Type 2 Diabetes: Part 1, Screening General Information The example intervention text shown below is embedded in the Clinical Quality Language (CQL) files for the Prediabetes and Type 2 Diabetes Part One: Screening artifact. Imple…

20. CDS Connect Work Group Meeting Summary 2-18-2021 (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/1256/CDS_Connect_WG_Feb2021_Summary.pdf
    February 24, 2021 - for estimated glomerular filtration rate from two different standards in order to completely profile kidney … disease.